VIA
IMMU

Vident Investment Advisory’s Immunomedics Inc IMMU Stock Holding History

Vident Investment Advisory’s Portfolio IMMU Stock Details IMMU Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q4 		– Sell
-17,344
Closed -$1.48M – 938
2020
Q3 		$1.48M Buy
17,344
+2,725
+19% +$138K 0.07% 370
2020
Q2 		$518K Buy
+14,619
New +$427K 0.03% 638
2018
Q1 		– Sell
-44,843
Closed -$725K – 957
2017
Q4 		$725K Buy
+44,843
New +$529K 0.03% 444

Vident Investment Advisory's IMMU Position: Q4 2020 in Review

Vident Investment Advisory sold out of Immunomedics Inc (IMMU) in Q4 2020, closing a stake of 17,344 shares — an estimated $1.48M sold.

Vident Investment Advisory first reported a position in IMMU in Q4 2017 and held it in 3 quarters. The position peaked at $1.48M in Q3 2020. 0 funds tracked by Wall St. Rank hold IMMU as of Q4 2020.

  • Vident Investment Advisory reported no remaining Immunomedics Inc position as of Q4 2020 after selling out during the quarter.
  • Vident Investment Advisory sold 17,344 Immunomedics Inc shares in Q4 2020, an estimated $1.48M.
  • Vident Investment Advisory first reported a position in Immunomedics Inc in Q4 2017 and held it in 3 quarters.
  • Vident Investment Advisory's Immunomedics Inc position peaked at $1.48M in Q3 2020.
  • 0 funds tracked by Wall St. Rank held Immunomedics Inc as of Q4 2020.

Based on Vident Investment Advisory's 13F filing for Q4 2020, filed 8 Feb 2021.